covid-19 pneumonia information

GigaGen develops new class of drugs to treat Covid-19

Reading now: 312
www.pharmaceutical-technology.com

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.US-based biotechnology company GigaGen has developed a new class of drugs, recombinant hyperimmunes, to potentially treat patients with Covid-19.

Hospitals across the country are using convalescent plasma to treat Covid-19. Obtained from people who recovered from the disease, convalescent plasma contains antibodies that could fight the infection.

However, plasma from many donors has weak antibody levels, limiting the manufacture of high-potency doses required to tackle the Covid-19 pandemic.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA